Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy
Changqing Fu,1 Xiaojue Zhu,2 Peiqi Xu,2 Yonghao Li2 1Clinical Laboratory, Zhangjiagang Fifth People’s Hospital, Suzhou University, Suzhou, Jiangsu 215621, People’s Republic of China; 2Clinical Laboratory, Zhangjiagang First People’s Hospital, Suzhou University, Suzhou,...
Main Authors: | Fu C, Zhu X, Xu P, Li Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/pharmacological-inhibition-of-usp7-promotes-antitumor-immunity-and-con-peer-reviewed-article-OTT |
Similar Items
-
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
by: Xiaoya Zhao, et al.
Published: (2021-05-01) -
E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer
by: Xiong Guo, et al.
Published: (2021-01-01) -
USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4
by: Tingzheng Pan, et al.
Published: (2021-09-01) -
USP7: Novel Drug Target in Cancer Therapy
by: Zhiru Wang, et al.
Published: (2019-04-01) -
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
by: Sol-Bi Shin, et al.
Published: (2020-11-01)